Elizabeth Stenger
Academic Appointment
- Assistant Professor of Pediatrics, Aflac Cancer & Blood Disorders Center, Emory University
Education
Degrees
- MSCR from Emory University
- MD from University of Pittsburgh
- BS from University of Notre Dame
Research
Publications
-
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.
Lancet Child Adolesc Health Volume: 8 Page(s): 740 - 750
10/01/2024 Authors: Kahn J; Brazauskas R; Bo-Subait S; Buchbinder D; Hamilton BK; Schoemans H; Abraham AA; Agrawal V; Auletta JJ; Badawy SM -
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
Am J Hematol Volume: 99 Page(s): 2037 - 2040
10/01/2024 Authors: Arnold SD; Bakshi N; Ross D; Smith C; Sinha C; Veludhandi A; Dutreuil V; Bai S; Meacham LR; Guilcher G -
Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.
Transplant Cell Ther Volume: 30 Page(s): 912.e1 - 912.e13
09/01/2024 Authors: George SA; Veludhandi A; Xiang Y; Liu K; Stenger E; Arnold SD; Mehta A; Schirmer DA; Spencer JB; Guilcher GMT -
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM -
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
Br J Haematol Volume: 205 Page(s): 243 - 255
07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM -
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
Am J Hematol Volume: 99 Page(s): 370 - 379
03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B -
Life after sickle cell disease, is it really uhuru?
Lancet Haematol Volume: 10 Page(s): e946 - e949
12/01/2023 Authors: Pecker LH; Akinsete AM; Carroll CP; Lanzkron S; Kuo KHM; Hulbert M; Stenger E; Darbari DS -
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH -
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
Pediatr Blood Cancer Volume: 70 Page(s): e30606
10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML -
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
Transplant Cell Ther Volume: 29 Page(s): 531.e1 - 531.e4
08/01/2023 Authors: Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L